Pan-Cancer Analysis of Oncogenic Role of RAD54L and Experimental Validation in Hepatocellular Carcinoma
Yongzhen Zhou,Chenjie Qiu,Qingsheng Fu,Tao Li,Xudong Zhang,Chunfu Zhu,Xihu Qin,Baoqiang Wu
DOI: https://doi.org/10.2147/jir.s426558
IF: 4.5
2023-09-12
Journal of Inflammation Research
Abstract:Yongzhen Zhou, 1, 2, &ast Chenjie Qiu, 3, &ast Qingsheng Fu, 2 Tao Li, 1 Xudong Zhang, 1 Chunfu Zhu, 1 Xihu Qin, 1 Baoqiang Wu 1, 2 1 Department of General Surgery, the Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, 213000, People's Republic of China; 2 Graduate School, Bengbu Medical College, Bengbu, 233003, People's Republic of China; 3 Department of General Surgery, Changzhou Hospital of Traditional Chinese Medicine, Changzhou, 213000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Baoqiang Wu, Email Background: RAD54L is a prominent member of the SWI2/SNF2 protein family, primarily involved in the homologous recombination repair (HRR) process, thereby playing a pivotal role in the repair of DNA double-strand breaks (DSBs). RAD54L has been implicated in the development of numerous tumors. Consequently, we aimed to investigate the potential contribution of RAD54L in pan-cancer. Methods: Various databases and analytical tools were employed for bioinformatics analysis. Moreover, in vitro experiments were conducted to corroborate the findings from the bioinformatics analysis and delve deeper into the role of RAD54L in hepatocellular carcinoma (HCC). Results: RAD54L expression demonstrated a significant elevation in the majority of tumors, and its overexpression was strongly associated with unfavorable survival outcomes. RAD54L displayed robust correlations with the infiltration levels of various immune cells, including cancer associated fibroblasts (CAFs), endothelial cells, and myeloid-derived suppressor cells (MDSCs). Additionally, associations were observed between RAD54L and key factors such as tumor mutation burden (TMB), microsatellite instability (MSI), multiple immune checkpoints, and immune cell infiltration. Moreover, a close relationship was observed between RAD54L expression levels in HCC and clinicopathological characteristics, as well as immune cell infiltration. Experimental techniques including qRT-PCR, Western blotting, colony-forming, Cell Counting Kit-8 (CCK-8), wound-healing, and transwell assays were employed, which collectively demonstrated that RAD54L promoted the proliferation and migration of HCC cells. Conclusion: RAD54L exhibits robust expression in both pan-cancer and HCC, exerting a significant influence on the proliferation and migration of HCC cells. These findings highlight its potential as a promising biomarker for pan-cancer and a prospective target for immunotherapy. Keywords: RAD54L, pan-cancer, tumor microenvironment, malignant behavior RAD54L is a member of the SWI2/SNF2 chromatin remodeling protein family, which plays a crucial role in mobilizing nucleosomes and DNA-associated proteins within mammalian cells. 1 Similar to other SWI2/SNF2 remodeling enzymes, RAD54L possesses the ability to translocate along DNA, inducing superhelical torsion and promoting accessibility of nucleosomal DNA. 2,3 The binding of RAD54L protein significantly enhances the stability of RAD51 nucleoprotein filaments formed on single-strand DNA (ssDNA) or double-strand DNA (dsDNA), thereby facilitating DNA strand exchange. 4 Furthermore, RAD54L actively promotes the formation of specific dsDNA structures that effectively bind to RAD51, facilitating the efficient repair and translocation of damaged DNA. Homologous recombination (HR), which involves the accurate repair of DNA double-strand breaks (DSBs) by utilizing intact sister chromatids as repair templates, relies heavily on the central role played by RAD54L. 5–7 Together with RAD51, RAD54L constitutes essential components of the eukaryotic HR machinery. In vitro, RAD51 proteins assemble with ssDNA to form helical nucleoprotein filaments that facilitate the crucial step of DNA strand exchange during HR. 4 In addition to its critical involvement in DNA damage repair (DDR), the absence of RAD54L leads to a significant increase in cell death resulting from DNA damage. 8 Notably, RAD54L has been implicated in promoting the development and progression of various tumor types, including pancreatic cancer (PAAD), 9 bladder cancer (BLCA), 10 glioblastoma (GBM), 11 and head and neck squamous cell carcinoma (HNSC), 12 among others. Consequently, RAD54L emerges as a potentially important protein in tumorigenesis. However, existing studies on the role of RAD54L in tumors have primarily focused on specific cancer types, limiting our comprehensive understanding of its involvement in oncogenesis. In recent years, numerous s -Abstract Truncated-
immunology